MARINUS PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
This LOAN AND SECURITY AGREEMENT (the “Agreement”) is entered into as of April 2, 2014, by and between Square 1 Bank (“Bank”) and Marinus Pharmaceuticals, Inc. (“Borrower”).
AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amended and Restated Indemnification Agreement (the “Agreement”) is entered into as of , by and among Marinus Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the undersigned party (the “Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EMPLOYMENT AGREEMENT effective as of November 22, 2013 between Marinus Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Edward F. Smith (the “Employee”).
ContractWarrant Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAW.
MARINUS PHARMACEUTICALS, INC. FORM OF NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This option satisfies in full all commitments that the Company has heretofore made to the Optionee with respect to the issuance of stock, stock options or other equity securities.
EMPLOYMENT AGREEMENTEmployment Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
EMPLOYMENT AGREEMENT effective as of November 2, 2012 between Marinus Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Gail M. Farfel, Ph.D. (the “Employee”).
THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS MARKED WITH [XXXXXXXXX] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...Technology Transfer Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS TECHNOLOGY TRANSFER AGREEMENT (the “Agreement”) is dated as of 4 December 2012 (the “Effective Date”), by and between Domain Russia Investments Limited, a private limited company incorporated and existing under the laws of England and Wales with registration number 7899075, having its registered office at The Broadgate Tower, Third Floor, 20 Primrose Street, City of London, EC2A 2RS, United Kingdom (“DRI”), and Marinus Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 21 Business Park Drive, Branford, Connecticut 06405, USA (“Company”). DRI and Company may each be referred to herein as a “Party” or, collectively, as “Parties.”
THIS DOCUMENT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED. REDACTED MATERIAL IS MARKED WITH [XXXXXXXXX] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES...Amended and Restated Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED AGREEMENT (“Restated Agreement”), effective on the 23rd day of May, 2008 (“Restatement Effective Date”), is entered into by and between Purdue Neuroscience Company (“Purdue”), a partnership formed under the laws of the state of Delaware with an office address at One Stamford Forum, Stamford, CT 06901 and Marinus Pharmaceuticals, Inc. (“Marinus”), a Delaware corporation with its principal place of business at 21 Business Park Drive, Branford, CT 06405.
ASSIGNMENT AND ASSUMPTION AGREEMENTAssignment and Assumption Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • California
This Assignment and Assumption Agreement (“Agreement”), signed as of December 4, 2012, is made by and among Domain Russia Investments Limited, a limited company organized under the laws of England and Wales with registration number 7899075, having its registered office at The Broadgate Tower, Third Floor, 20 Primrose Street, City of London, EC2A 2RS, United Kingdom (“DRI”), Marinus Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 21 Business Park Drive, Branford, Connecticut 06405, USA (“Marinus” or “Company”), and NovaMedica LLC, a limited liability company organized under the laws of the Russian Federation with an address of 10113, bldg. 38, Sokolnichesky Val Street, Moscow, Russian Federation (“NovaMedica” and, together with DRI and Marinus, the “Parties”, and each of NovaMedica, Marinus, and DRI, a “Party”).
CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENTClinical Development and Collaboration Agreement • May 12th, 2014 • Marinus Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CLINICAL DEVELOPMENT AND COLLABORATION AGREEMENT (the “Agreement”) is made effective as of the 25th day of June, 2013 (the “Effective Date”), by and between NovaMedica, LLC (“NovaMedica”), a limited liability company organized under the laws of the Russian Federation with an address of 10113 bldg 38, Sokolnichesky Val Street Moscow Russian Federation, and Marinus Pharmaceuticals, Inc. (“Marinus” or “Company”), a corporation organized under the laws of the State of Delaware, USA, and having its place of business at 142 Temple Street, Suite 205, New Haven, Connecticut 06510, USA. For the purposes of this Agreement, “Party” means NovaMedica and Marinus, individually, and “Parties” means NovaMedica and Marinus, collectively.
